1 trillion bacterial cells with around 1000 species but >90% of cells from just 2 phyla. The gut microbiota of most vertebrates is broadly similar to the human gut microbiota.
Microbes are not distributed uniformly.
Transit time, available nutrients, physico-chemical properties & antimicrobial secretions influence what microbe species can live in the gut and where.
The epithelium is a ‘privileged’ site.
Germ free animals are not different morphologically, metabolically & immunologically.
The activities of our microbiome profoundly influences our health.
A site of pathology: Diarrhoeal disease, Gastric ulcers & Colorectal cancer.
Gut functions are a risk factor for other diseases: obesity, diabetes, cardiovascular disease.
MOLECULES absorbed from the gut lead to systemic effects:
This includes molecules of microbial origin!
Large intestine particular involvement: Fermentation, absorption of short chain FAs.
What are all of these associated with?
Rheumatoid arthritis, cardiovascular disease, autism spectrum disorder, type 2 diabetes, food allergy.
All these are also associated with gut microbiome differences!
What are example changes and how they impacted ‘normal microbes’ for our gut?
In the aim to decrease infectious diseases, improvements in public health led to decreases in host susceptibility and in disease transmission.
All essentially leads to a change in the microbial combined genome!
Culture only samples cells that remain live & viable after handling protocol, whilst sequencing only samples cells that yield DNA after extraction protocol.
Culture only samples what grows to detection limits under culture protocol, whilst sequencing only samples what is targeted by primers under PCR protocol.
Culture can potentially distinguish anything that has different physiology/biochemistry, whilst sequencing only distinguishes what has different rRNA sequence.
In culture, relative abundance of each type reflects colony-forming units, not individual cells. In sequencing, relative abundance of each type reflects amplification success & gene copy number, not individual cells.
Essentially, culture is a better way to characterise PHYSIOLOGY, but sequencing can characterise the community and determine which parts contribute to a problem.
Both true!
People may have differing ‘strains’ within these phyla. All humans have distinct microbiomes (membership AND distribution) at strain level.
acidity in the stomach (<10^4 cells/mL)
mild acidity, bile salts and fast transit in the duodenum/jejunum (10^3-10^5 cells/mL)
medium transit, lymphoid tissue, bile salts in the ileum (10^8 cells/mL)
The large intestine (10^11-10^12 cells/mL): lymhpoid tissue, slow transit, low bile salts, soluble nutrient depleted.
FLOW RATE: sets growth rate
PHYSICO-CHEMICAL STRESS: oxygen, pH, antimicrobials
NUTRIENT AVAILABILITY: what compounds we eat & what we secrete
BIOLOGICAL PROCESSES: competition w other microbes, competition w host
Organisms in the colon can efficiently utilise the fibre we cannot digest, i.e. ‘Digestion Resistant Carbohydrates’ (DRC). Microbial processes dominate polysaccharide fermentation, assisted by the high cell density (>10^10 cells/mL) and typical slow transit time of the colon (up to 30 hours).
Longitudinal gradients from the stomach to the colon include:
Also a cross-sectional gradient particularly in the colon; less at the epithelial surface and immediate mucous layer and more at the inner mucous layer (due to antimicrobial peptides, mucin secretions)
The mid (ileum) and distal (colon) parts of the GIT have the highest concentrations of microbes - and these are overwhelmingly bacteria.
The vast majority of bacterial cells in mammalian guts belong to species with just 2 phyla - Bacteroidetes & Firmicutes. Proteobacteria, Verrucomicrobia, Actinobacteria & Fusobacteria are also nearly always represented but each with comparatively few species.
People vary in the relative numbers of all these phyla BUT MOSTLY people vary in which species & strains of Bacteroidetes & Firmicutes are present.
The gut bacteria contribute the ability to digest non-starch polysaccharide - without them most plant-based foods are a poor source of energy.
Fecal microbe samples are a direct measure of your potential to degrade fibre. They are also a proxy measure of the ‘history’ of YOUR system biology.
The chemical composition of intestinal contents is profoundly shaped by microbial metabolic activity.
Activity of microbes means:
Developmental influence of our microbes means:
> DIFFERENCES IN STRUCTURAL INTERFACE BW GUT & REST OF BODY SYSTEM
—- gut barrier
—- absorption efficiency
> DIFFERENCES IN HOW WE PERCEIVE & RESPOND TO OUR ENVIRONMENT
— regulation of IR
- metabolic regulation
- appetite regulation
1) Nutrition & metabolism:
- energy balance
- detoxification
- vitamins
2) Development:
- intestinal tissue
- adipose tissue
3) Immune state:
- TC subtype ratio
- tolerance
> No single species is essential to a normal phenotype or can deliver it
Differences in microbiome composition can give different health outcomes
> > Diseases that have immunophenotype / energy balance as risk factors effectively have gut microbiome structure as a risk factor
Some infections are endogenous as a result of disturbance (C. difficile).
Some infections are acquired.
The host defenses include normal flora, mucin, innate immunity, and adaptive immunity.
Endotoxin, Exotoxin, Cytopathology.
Viral gastroenteritis, E. coli/Shigella, Campylobacter, Staphyloccocus.